2026–27 COVID-19 vaccine approvals and rollout uncertainty

Updated Moderna, Pfizer, and Novavax vaccines are becoming available in the U.S., but federal eligibility, CDC/HHS guidance, insurance rules, pediatric ordering, VFC operations, and supply remain unsettled. A brief reports a two-dose schedule for adults 65 and older; full recommendations and implementation details need verification.